Ojala K, Weber T
Scand J Clin Lab Invest. 1983 Jun;43(4):313-5.
The discriminating power of HBD, LD and of the HBD/LD ratio in comparison with LD1/LD2 and LD5/LD4 ratios in acute myocardial infarction and hepatic disease is evaluated. The results demonstrate that there are no clinical reasons for the determination of the HBD when a method using the conditions of the Committee of Enzymes of the Scandinavian Society for Clinical Chemistry (SCE) is used.
评估了HBD、LD以及HBD/LD比值相较于LD1/LD2和LD5/LD4比值在急性心肌梗死和肝病中的鉴别能力。结果表明,当使用斯堪的纳维亚临床化学学会(SCE)酶委员会规定的条件的方法时,测定HBD没有临床依据。